Pilot study identifies plasma gelsolin's potential to indicate inflammation in pregnant women with ruptured membranes, suggesting new diagnostic avenues.
Plasma gelsolin decreases with the progression of pregnancy and intrauterine inflammation and may particularly reflect the progression of intrauterine inflammation in cases of preterm premature rupture of membrane. Gelsolin has the potential to serve as a novel biomarker for detecting inflammatory conditions that are not readily identified by conventional markers.
No takes yet. Share an insight, caveat, or question.
Miyazaki et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: